How common is hand–foot syndrome (palmar-plantar erythrodysaesthesia) with Cometriq (cabozantinib) capsules?

Hand–foot syndrome (palmar-plantar erythrodysaesthesia) is very common with Cometriq (cabozantinib) capsules (at least 1 in 10 patients, across all grades) and was among reactions experienced by at least 20% of patients.